Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
J Enzyme Inhib Med Chem. 2012 Feb;27(1):5-11. doi: 10.3109/14756366.2011.568415. Epub 2011 Jul 8.
Development of inexpensive and safe enzymatic assays to screen for putative neuraminidase inhibitors.
Validate the use of recombinant neuraminidase expressed in baculovirus located on the viral surface capsule to develop a neuraminidase inhibitor screening assay.
Recombinant baculovirus particles displaying neuraminidase N1 and N3 were used as enzyme sources. The assay set-up required the use of 2'-(4-methylumbelliferyl)-α-D-acetyl neuraminic acid as substrate and oseltamivir carboxylate as benchmark inhibitor.
The assay was set up in a standard 96-well plate. The within- and between-assay coefficients of variation were, on average, less than 10%. The 50% inhibitory concentration values of the inhibitor were in good agreement with those determined by independent kinetic experiments.
The assay showed satisfactory within- and between-assay repeatability. The obtained results suggest that recombinant baculovirus expressing neuraminidase located on the virus membrane capsule can be used to set up affordable and reliable neuraminidase inhibitors screening assays.
开发廉价且安全的酶促分析方法,以筛选潜在的神经氨酸酶抑制剂。
验证使用位于病毒表面囊泡上的杆状病毒表达的重组神经氨酸酶来开发神经氨酸酶抑制剂筛选分析。
使用展示神经氨酸酶 N1 和 N3 的重组杆状病毒颗粒作为酶源。该分析需要使用 2'-(4-甲基伞形酮基)-α-D-乙酰神经氨酸作为底物,奥司他韦羧酸盐作为基准抑制剂。
该分析在标准的 96 孔板中进行。平均而言,实验内和实验间变异系数小于 10%。抑制剂的 50%抑制浓度值与通过独立的动力学实验确定的值吻合良好。
该分析显示出令人满意的实验内和实验间可重复性。获得的结果表明,位于病毒膜囊泡上表达神经氨酸酶的重组杆状病毒可用于建立经济且可靠的神经氨酸酶抑制剂筛选分析。